A prospective multicentre randomized placebo-controlled superiority trial in patients with suspected bacterial endophthalmitis after cataract surgery on the adjuvant use of intravitreal dexamethasone to intravitreal antibiotics.
Sonia S ManningLuana C UgaharyEric W LindstedtRené J WubbelsJaap T van DisselJan T G JansenIvan GanArnoud T van GoorCarlien A BennebroekDymph J van der WerfAnnette Ossewaarde-van NorelChris C Mayland NielsenMauk TilanusPieter R van den BiesenPeter A SchellekensEllen La HeijKoorosh FaridpooyaKoen A van OverdamMarc VeckeneerJan C van MeursPublished in: Acta ophthalmologica (2017)
Intravitreal dexamethasone without preservatives as an adjuvant to intravitreal antibiotics does not improve visual acuity (VA) in patients treated for suspected bacterial endophthalmitis after cataract surgery.
Keyphrases
- cataract surgery
- vascular endothelial growth factor
- double blind
- placebo controlled
- age related macular degeneration
- diabetic retinopathy
- phase iii
- phase ii
- study protocol
- clinical trial
- early stage
- low dose
- open label
- high dose
- endothelial cells
- randomized controlled trial
- pulmonary embolism
- radiation therapy
- optical coherence tomography
- cross sectional
- locally advanced